Form 4 for TMDX TransMedics Group, Inc.
Accepted 2026-02-20 00:00:00 ET · period of report 2026-02-18 · accession 0001193125-26-061341 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-20 | 2026-02-18 | TMDX | Cecere Giovanni | Chief Commercial Off | A - Grant | $0.00 | +11.1K | 19.1K | +139% | $0 |
| D | 2026-02-20 | 2026-02-18 | TMDX | Cecere Giovanni | Chief Commercial Off | A - Grant | $0.00 | +16.7K | 16.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-18 | A | A | 11,082 | $0.00 | 19,057 | D | — | — | (F1) Consists of 11,082 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-02-18 | A | A | 16,734 | $0.00 | 16,734 | D | $135.50 · — to 2036-02-18 | 16,734 Common Stock | (F2) The option vests as to 25% of the shares underlying the option on February 18, 2027 and as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service. |